Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer is correlated with survival

Clinical Cancer Research

Volumn 7, Issue 7, 2001, Pages 1850-1855

  Brabender, Jan ^a,b   Danenberg, Kathleen D ^a   Metzger, Ralf ^b   Schneider, Paul M ^b   Park, JiMin ^a   Salonga, Dennis ^a   Hölscher, Arnulf H ^b   Danenberg, Peter V ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA; ONCOPROTEIN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; GENE EXPRESSION; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ONCOGENE NEU; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ERBB-2; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL ANALYSIS;

EID: 0034777482     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Non-small cell lung cancer
2. Protein-tyrosine kinases, oncogenes and cancer
3. The biology of erbB-2/neu/HER-2 and its role in cancer
4. Epidermal growth factor and its receptor
5. Human squamous cell lung cancers express increased epidermal growth factor receptors
6. Expression of epidermal growth factor receptor (EGFR) in human lung tumors
7. Epidermal growth factor receptors in non-small cell lung cancers
8. The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival
9. A comparison of epidermal growth factor receptor levels and other prognostic parameters in non-small cell lung cancer
10. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung
11. Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER-2 in patients with systemically untreated non-small cell lung cancer: An immunohistochemical study on cryosections
12. Immunocytochemical markers in stage 1 lung cancers: Relevance to prognosis
13. Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer
14. p185 neu expression in human lung adenocarcinomas predicts shortened survival
15. Expression of the neu gene-encoded protein (P185neu) in human non-small cell carcinomas of the lung
16. HER-2/neu expression in archival non-small cell lung carcinomas using FDA-approved Hercep test
17. C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinoma
18. Real time quantitative PCR
19. A novel method for real time quantitative RT-PCR
20. Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, carcinoma sequence
21. Asymptomatically efficient rank invariant procedures
22. 2 statistics
23. 2 statistics for small samples
24. Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma
25. Overexpression of the c-erbB-2/neu-encoded p185 protein in primary lung cancer
26. Alterations of K-ras, p53, and erbB-2/neu in human lung adenocarcinomas
27. Localized adenocarcinoma of the lung: Oncogene expression of erbB-2 and p53 in 150 patients
28. Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations
29. Detection of erbB-2 amplifications in tumors and sera from esophageal carcinoma patients
30. Increased expression of onithine decarboxylase mRNA in human esophageal carcinoma
31. Expression and activation of erbB-2 and epidermal growth factor receptor in lung adenocarcinomas
32. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancer and adjacent benign lung
33. Enzyme-linked immunoabsorbent assay of epidermal growth factor receptor in lung cancer: Comparison with immunohistochemistry, clinicopathological features and prognosis
34. Epidermal growth factor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression
35. Correlation of intrinsic chemoresistence to non-small cell lung cancer cell lines with HER-2/neu gene expression but not with ras gene mutations
36. Correlation between intrinsic chemoresistance and HER-2/neu gene expression, p53 mutations and cell proliferation characteristics in non-small cell lung cancer cell lines
37. neu in the HER-2/neu transfected human lung cancer cells
38. Interrelationships between cellular nucleotide excision repair, cisplatin cytotoxicity, HER-2/neu gene expression, and epidermal growth factor receptor level in non-small lung cancer cell lines
39. Specifity of HercepTest in determining the HER-2/neu status of breast cancers using the United States Food and Drug Administration approved scoring system